Niftypharma
Sun Pharma in Dynamic SupportSun Pharma is in dynamic support line/trend line. And NIfty Pharma is also formed hammer candle on daily basis, moreover sun pharma also gave bullish engulfing pattern, so its looking towards to move up with the minimum target of 670 in a week or in good number of days!
MyAlgo : xMRSI-Progresser: Intraday : 21Sep-Glenmark-ShortBased on my "xMRSI-Progresser" predictive trading methodologies, its going to be a RED candle on 21-Sep-2018 for Glenmark
Sell Below(5Min candle close): 669 for targets -
T1: 664
T2: 661
T3: 657.8
SL: 674.4
Note: These calls are based on my own analysis. It may or may not work well for you.So please carefully consider whether it is suitable for you and please do your own research before attempting any. The profit/loss made by you due to this call, is solely your own responsibility. Thanks, All the best. Happy Trading. :-)
Will Nifty pharma going to fall ?Wedge pattern formed and broken in Nifty Pharma.
Trade Levels:
Short level - 9395
End level - 8985
LUPIN BUY (LONG)Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600
Lupin gets USFDA nod to market pain relief, colonoscopy drugs and also gets FDA approval for generic Percocet tablets .
Lupin recently received FDA approval for generic Suprep Bowel Prep Kit and Suprep kit approval It may add 5% to Lupin’s EPS for FY18 earnings.
In addition the pharma major’s Goa facility has been cleared by the US FDA.
Lupin Result: Revenue grew 26% YoY to INR 44.8b Gross margin was stable QoQ at 71.0%. EBITDA rose 27% YoY to INR 12.2b with margin of 27% . EBITDA margin improvement was primarily driven by strong growth in US sales (+53% YoY, +8% QoQ; despite R&D as % of sales at 12.9%) and forex gain of INR 270m. PAT of INR 6.3b was impacted by 1% due to a high tax rate of 39%.
Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600
Ascending Triangle on Sun Pharma - LongAscending Triangle formation on Sun Pharma and showing bullish trend.
Trade
Buy abv 710
Target - 720
Stop loss - 703
